Sign in
Explore the registryTrack Enfortumab vedotin and pembrolizumab's trials

Chrono-EVP

The Impact of Time-of-day Administration of EV/P on Objective Response Rate in Adults With Advanced Bladder Cancer

Enfortumab vedotin and pembrolizumab (EV/P)OngoingNot yet recruitingPhase 3Open NCT07346053 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

Chrono-EVP · Trial Tracker · ComplyRx